pPLUS®AAV-eGFP plasmid offers a streamlined solution for gene therapy discovery, allowing researchers to get our full set of high-performance plasmids that are readily available off the shelf. With competitive pricing, pPLUS®AAV-eGFP plasmid is easily modifiable with our engineering services for fined tuned transgene design to ensure high yielding large-scale production and avoid redesign.
pPLUS®AAV-eGFP plasmid offers a streamlined solution for gene therapy discovery, allowing researchers to get our full set of high-performance plasmids that are readily available off the shelf. With competitive pricing, pPLUS®AAV-eGFP plasmid is easily modifiable with our engineering services for fined tuned transgene design to ensure high yielding large-scale production and avoid redesign.
The pPLUS® AAV eGFP plasmid is engineered for stability, high yield, and manufacturing readiness, minimizing recombination pressure from ITRs through a streamlined backbone architecture. Its rationally optimized design for production of most AAV serotypes and removes the need for further redesign when swapping eGFP for your payload. With eZyvec® modular assembly, promoters, payloads, and regulatory elements can be rapidly exchanged to accelerate design–build–test cycles. Combined with high performance features—including Kan/Neo selection, strong CMV promoter , WPRE, and robust replication elements—it provides a reliable, flexible foundation for advancing AAV production.
Benefits:
Please select your country so we can show you products that are available for you.
The content of our website is always available in English and partly in other languages. Choose your preferred language and we will show you the content in that language, if available.